Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing the Diagnostic Supremacy of Sequencing-only Approaches in Hematologic Malignancies: an Observational Trial

NCT05046444 is registered in ClinicalTrials.gov with Munich Leukemia Laboratory as lead sponsor.

NCT NCT05046444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05046444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing the Diagnostic Supremacy of Sequencing-only Approaches in Hematologic Malignancies: an Observational Trial
Lead sponsor
Munich Leukemia Laboratory
Phase
Observational
Overall status
Recruiting
Start date
January 19, 2022
Completion date
October 1, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancy, leukemia, rare diseases, refractory leukemia, refractory lymphoma, unknown primary tumors